Clinical trial
a Phase II Study in Primary Central Nervous System Lymphoma
NCT00455286 · National Health Research Institutes, Taiwan, Other · Unknown status
Key facts
| NCT number | NCT00455286 |
|---|---|
| Title | a Phase II Study in Primary Central Nervous System Lymphoma |
| Official title | High-Dose Methotrexate Plus Steroid Followed by Concurrent Whole Brain Chemoradiation With Temozolomide for Immunocompetent Patients With Primary Central Nervous System Lymphoma - a Phase II Study |
| Lead sponsor | National Health Research Institutes, Taiwan, Other |
| Collaborators | National Taiwan University Hospital Mackay Memorial Hospital China Medical University Hospital National Cheng-Kung University Hospital Chi Mei Medical Hospital Taichung Veterans General Hospital |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Primary Central Nervous System Lymphoma |
| Intervention type | Drug |
| Interventions | Methotrexate, Methylprednisolone, Temozolomide |
| Enrollment | 25 |
| Start date | Nov 1, 2006 |
| Completion | Nov 1, 2011 |
| First posted | Apr 3, 2007 |
| Last update posted | Apr 4, 2007 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: